Back to Search
Start Over
Understanding risk factors, screening, and treatment of postmenopausal osteoporosis.
- Source :
-
Orthopedics [Orthopedics] 2008 Jul; Vol. 31 (7), pp. 676-80. - Publication Year :
- 2008
-
Abstract
- Between 30% and 50% of American women will endure a clinical fracture during their lifetime due to the loss of bone mineral density that occurs with menopausal estrogen loss. This article is part one in a two-part series on osteoporosis. Part two will appear in the August 2008 issue of ORTHOPEDICS.
- Subjects :
- Absorptiometry, Photon
Bone Density Conservation Agents administration & dosage
Bone Density Conservation Agents therapeutic use
Calcitonin therapeutic use
Diphosphonates adverse effects
Diphosphonates therapeutic use
Female
Humans
Middle Aged
Osteoporosis, Postmenopausal diagnosis
Osteoporosis, Postmenopausal epidemiology
Osteoporosis, Postmenopausal prevention & control
Raloxifene Hydrochloride therapeutic use
Risk Factors
Teriparatide therapeutic use
Osteoporosis, Postmenopausal therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0147-7447
- Volume :
- 31
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Orthopedics
- Publication Type :
- Academic Journal
- Accession number :
- 18705561
- Full Text :
- https://doi.org/10.3928/01477447-20110505-09